ResearchMoz

Implantable Medical Devices Market (Reconstructive Joint Replacement, Spinal Implants, Cardiovascular Implants, Dental Implants, Intraocular Lens And Breast Implants) - U.S. Industry Analysis, Size, Share, Trends, Growth And Forecast, 2012 - 2018

Transparency Market Research
Published Date » 2013-01-23
No. Of Pages » 98

This report covers major aspects of the U.S. implantable medical devices market. It covers the performance of the major types of implantable devices in terms of their revenue, and the market is classified according to the number of procedures performed. The overall implantable medical devices market is classified as orthopedic implants, cardiovascular implants and other (dental, intraocular lens and breast) implants market. The report also provides extensive analysis of the sub-segments of the market considering 2011 as the base year for market size calculations and forecast from 2012 to 2018.

The orthopedic implants market is classified on the basis of types of orthopedic implants and orthopedic implantation procedures. The analysis covers the estimated revenues from 2010 to 2011 and forecast of these major segments from 2012 to 2018. Similar detailed analysis is conducted for cardiovascular implants, intraocular implants and breast implants. The overall analysis of the competitiveness of the U.S. market for the above products is included in the report. These factors along with the strategic recommendations would be helpful in taking fair corporate decisions related to the products’ market.

In addition, this report covers the major players currently active in the U.S. implantable devices market. The company profiling done in this report will be of vital assistance in mapping the competition in the market. The profiles cover the financial and strategic overview of the key players and their SWOT analysis and recent developments.

Secondary research has been employed for deriving the market numbers for each segment of the research report and have been further validated with C-level executives of major companies operating in the implantable medical devices market through means of primary research to finally come up with definite results. This research is specially designed to estimate and analyze the performance of prime implantation devices in the U.S. market. The research provides in-depth analysis of the devices’ market revenue and trend analysis. The report also covers all the major product types and procedures of the implantable medical devices market and provides detailed analysis, historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies, winning imperatives for them by segmenting the U.S. market as below:

U.S. implantable medical devices market, product segmentation

  • Orthopedic implants
  • Reconstructive joint replacement
  • Spinal implants

Cardiovascular implants

  • Dental implants
  • Intraocular lens
  • Breast implants
  • Other implants

U.S. implantable medical devices market, by procedures

  • Orthopedic procedures
  • Cardiovascular procedures
  • Other procedures

The in-depth research and high level analysis will allow implantable medical device providers, lawmakers, equipment manufacturers, medical companies and research and development agencies to make informed decisions about implantable device product manufacturing, designing, marketing, growth strategies and gain competitive advantage.
Table of Content:

Chapter1Preface
1.1ResearchScopeAndDescription
1.2Research Methodology

Chapter2ExecutiveSummary

Chapter3U.S.ImplantableMedicalDevicesMarketAnalysis
3.1Introduction
3.1.1MarketEnvironment
3.1.2PolicyIssues
3.1.3U.S.KeyIndicatorsForImplantableMedicalDevices
3.2MarketDrivers
3.2.1 HighIncidenceOfChronicDegenerativeDiseases
3.2.2IncreaseInAgingPopulation
3.2.3RiseInPurchasingParityAndIncreaseInHealthcareExpenditure
3.3MarketRestraints
3.3.1HighPriceOfImplantableDevices
3.4MarketOpportunities
3.4.1TechnicalInnovation
3.5Porter’sFiveForcesAnalysis
3.5.1BargainingPowerOfBuyers
3.5.2BargainingPowerOfSuppliers
3.5.3ThreatOfSubstitutes
3.5.4ThreatOfNewEntrants
3.5.5CompetitiveRivalry
3.6MarketAttractivenessAnalysis
3.6.1U.S.ImplantableMedicalDevicesMarket,MarketAttractivenessAnalysis,2011

Chapter4U.S.ImplantableMedicalDevicesMarket,ProductSegmentation
4.1Overview
4.1.1CurrentScenario
4.1.1.1U.S.ImplantableMedicalDevicesMarket–TrendsandForecast,2010-2018(USDMillion)
4.1.2U.S.OrthopedicImplantsMarket
4.1.2.1Currentscenario
4.1.2.2ReconstructiveJointReplacements
4.1.2.2.1U.S.ReconstructiveJointReplacementMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.2.3SpinalImplants
4.1.2.3.1U.S.SpinalImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.2.4Orthobiologics
4.1.2.5Traumafixationimplants
4.1.2.6OtherImplants
4.1.3CardiovascularImplants
4.1.3.1U.S.CardiovascularImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.3.2PacingDevices
4.1.3.3StructuralCardiacDevices
4.1.3.4CardiacStents
4.1.4DentalImplants
4.1.4.1U.S.DentalImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.5IntraocularLens(Iols)
4.1.5.1U.S.IntraocularLensMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.6BreastImplants
4.1.6.1U.S.BreastImplantsMarket–TrendsandForecast,2010–2018(USDMillion)
4.1.7OtherImplants
4.1.7.1U.S.OtherImplantableMedicalDevicesMarket,TrendsandForecast,2010–2018(USDMillion)

Chapter5U.S.ImplantableMedicalDevicesMarket,ByProcedures
5.1Overview
5.2U.S.OrthopedicImplantProcedures–TrendsAndForecast,2010–2018
5.2.1U.S.OrthopedicImplantProceduresMarket,2010–2018
5.2.2KneeReplacements
5.2.3SpinalFusionAndFixation
5.2.3.1U.S.SpinalFusionandFixationProceduresMarket,TrendandForecast,2010-2018
5.2.4FractureRepairProcedures
5.3U.S.CardiovascularImplantProcedures–TrendsAndForecast,2010–2018
5.3.1U.S.CardiovascularImplantProceduresMarket,2010–2018
5.3.2StentingProcedures
5.3.2.1U.S.StentingProceduresMarket,TrendandForecast,2010–2018
5.3.3DefibrillatorImplantation
5.3.3.1U.S.DefibrillatorImplantationProceduresMarket,TrendAndForecast,2010–2018
5.4U.S.OtherImplantProcedures–TrendsAndForecast,2010–2018
5.4.1IntraocularLensImplantProcedures
5.4.2BreastAugmentation
5.4.2.1U.S.BreastAugmentationProceduresMarket,TrendandForecast,2010–2018

Chapter6CompetitiveLandscapeAndRecommendations
6.1MarketShareAnalysisOfKeyPlayers,2011
6.1MarketStrategyForSuccess
6.2BarriersToBeConsidered

Chapter7CompanyProfiles
7.1AbbottLaboratories
7.1.1CompanyOverview
7.1.2FinancialOverview
7.1.3SwotAnalysis
7.1.4ProductPortfolio
7.1.1StrategicDevelopments
7.1.1.1BusinessDiversification
7.1.1.2R&DInitiatives
7.1.1.3InvestingInEmergingMarkets
7.1.2RecentDevelopments
7.2AlconLaboratories
7.2.1CompanyOverview
7.2.2FinancialOverview
7.2.3SwotAnalysis
7.2.4ProductPortfolio
7.2.5RecentDevelopments
7.3BiometIncorporated
7.3.1CompanyOverview
7.3.2FinancialOverview
7.3.3SwotAnalysis
7.3.4StrategicDevelopments
7.3.4.1Mergers,AcquisitionsAndTakeovers
7.3.5RecentDevelopments
7.4BauschAndLombIncorporated
7.4.1CompanyOverview
7.4.2SwotAnalysis
7.4.3StrategicDevelopments
7.4.3.1Mergers,AcquisitionsAndTakeovers
7.4.3.2NewProductLaunches
7.4.4RecentDevelopments
7.5BostonScientificCorporation
7.5.1CompanyOverview
7.5.2FinancialOverview
7.5.3SwotAnalysis
7.5.4StrategicDevelopments
7.5.4.1Mergers,AcquisitionsAndTakeovers
7.5.4.2NewProductApprovals
7.5.5RecentDevelopments
7.6JohnsonAndJohnson
7.6.1CompanyOverview
7.6.2FinancialOverview
7.6.3SwotAnalysis
7.6.4StrategicDevelopments
7.6.4.1Mergers,AcquisitionsAndTakeovers
7.6.4.2NewProductApprovalsAndLaunch
7.6.5RecentDevelopments
7.7MedtronicIncorporated
7.7.1CompanyOverview
7.7.2FinancialOverview
7.7.3SwotAnalysis
7.7.4ProductPortfolio
7.7.5StrategicDevelopments
7.7.6RecentDevelopments
7.8St.JudeMedicalIncorporated
7.8.1CompanyOverview
7.8.2FinancialOverview
7.8.3SwotAnalysis
7.8.4StrategicDevelopments
7.8.4.1SignificantR&DInvestmentsForNewProductDevelopment
7.8.4.2MergersAndAcquisitions
7.8.5RecentDevelopments
7.9SmithAndNephewPlc
7.9.1CompanyOverview
7.9.2FinancialOverview
7.9.3SwotAnalysis
7.9.4StrategicDevelopments
7.9.4.1Mergers,AcquisitionsAndTakeovers
7.9.5RecentDevelopments
7.10StrykerCorporation
7.10.1CompanyOverview
7.10.2FinancialOverview
7.10.3SwotAnalysis
7.10.4StrategicDevelopments
7.10.4.1Mergers,AcquisitionsAndTakeovers
7.10.5RecentDevelopments
7.11SynthesIncorporated
7.11.1CompanyOverview
7.11.2FinancialOverview
7.11.3SwotAnalysis
7.11.4StrategicDevelopments
7.11.5RecentDevelopments
7.12ZimmerHoldingsIncorporated
7.12.1CompanyOverview
7.12.2FinancialOverview
7.12.3SwotAnalysis
7.12.4StrategicDevelopments
7.12.5RecentDevelopments

List of Tables


Table 1 The U.S. Implantable Medical Devices Market: Snapshot

List of Figures


fig. 1 U.S. Implantable Medical Devices Market, By Types Of Implants, 2011 (Usd Million)
Fig. 2 Porter’s Five Forces Analysis For The U.S. Implantable Medical Devices Market
Fig. 3 U.S. Implantable Medical Devices Market Attractiveness Analysis, 2011
Fig. 4 U.S. Implantable Medical Devices Market, 2010 – 2018 (Usd Million)
Fig. 5 U.S. Orthopedic Implants Market, 2010 – 2018 (Usd Million)
Fig. 6 U.S. Reconstructive Joint Replacement Market, 2010 – 2018 (Usd Million)
Fig. 7 U.S. Spinal Implants Market, 2010 – 2018 (Usd Million)
Fig. 8 U.S. Cardiovascular Implants Market, 2010 – 2018 (Usd Million)
Fig. 9 U.S. Dental Implants Market, 2010 – 2018 (Usd Million)
Fig. 10 U.S. Intraocular Lens Market, 2010 – 2018 (Usd Million)
Fig. 11 U.S. Breast Implants Market, 2010 – 2018 (Usd Million)
Fig. 12 U.S. Other Implantable Medical Devices Market, 2010 – 2018 (Usd Million)
Fig. 13 U.S. OrthopedicImplants Procedures Market, 2010 – 2018 (Million)
Fig. 14 U.S. Spinal Fusion And Fixation Procedures Market, 2010 – 2018 (Million)
Fig. 15 U.S. Cardiovascular Implant Procedures Market, 2010 – 2018 (Million)
Fig. 16 U.S. Stenting Procedures Market, 2010 – 2018 (Million)
Fig. 17 U.S. Defibrillator Implantation Procedures Market, 2010 – 2018 (Million)
Fig. 18 U.S. Breast Augmentation Procedures Market, 2010 – 2018 (Million)
Fig. 19 Abbott Laboratories: Net Sales, 2009 – 2011 (Usd Million)
Fig. 20 Alcon Laboratories: Net Sales, 2009 – 2011 (Usd Million)
Fig. 21 Biomet Incorporated: Net Sales, 2009 – 2011 (Usd Million)
Fig. 22 Boston Scientific: Net Sales, 2009 – 2011 (Usd Million)
Fig. 23 Johnson & Johnson: Net Sales, 2009 – 2011 (Usd Million)
Fig. 24 Medtronic Inc: Net Sales, 2009 – 2011 (Usd Million)
Fig. 25 St Jude Medical Inc.: Net Sales, 2009 – 2011 (Usd Million)
Fig. 26 Smith And Nephew Plc: Net Sales, 2009 – 2011 (Usd Million)
Fig. 27 Stryker Corporation: Net Sales, 2009 – 2011 (Usd Million)
Fig. 28 Synthes Corporation: Net Sales, 2009 – 2011 (Usd Million)
Fig. 29 Zimmer Holdings Inc.: Net Sales, 2009 – 2011 (Usd Million)

Upcoming Reports:

Aptamers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Aptamers refer to short strands of nucleic acids or peptide molecules capable of forming secondary and tertiary structures. These molecules bind specifically to the cellular targets and are created by selecting randomly from the complex libraries of synthetic nucleic acids. These receptor molecules can be modified in order to enhance the stability and availability in biological environments. Aptamers possess potential applications in research, clinical, industrial and medical areas. Since the 1990s, aptamers have been tested for their clinical relevance.  Aptamers are...
Biomedical Applications Of Nanoscale Devices Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Nanodevices have been introduced via use of nanotechnology and they have been of significant aid for the healthcare applications. The Nanodevices can be defined to be in the size ranging within the dimensions of 100 nm in size. Growing importance of diagnostics and demand for early detection with quick turnaround time has triggered the growth of their application in medical and diagnostic devices. The major advantages of  Nanoscale devices are as below: The sample required is minimal Less reagents required Multiple tests can be performed on single platform...
Digital Terrestrial Television (DTT) Receivers Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 - 2018
By - Transparency Market Research
Digital terrestrial television is an advanced technology of analog television and evolution of broadcast television. Digital television market is designed to offer quality television experience to customers. In terrestrial implementation of digital television technology, instead of cable television and satellite connection, conventional antenna is used to provide better quality experience. Western Europe, France, Denmark, Spain, Norway and Sweden have successfully completed analog switch-off (ASO) and have become fully digitalized. There was a large potential market for DTT...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Scientists Identify Cure for Dengue
Apr 18, 2014  
In a breakthrough discovery that can change the way dengue is treated, scientists have identified a drug target for the deadly dengue viruses. This discovery may help pave the way for discovery of vaccines that can cure this condition that affects nearly 390 million people throughout the world each year.  Scientists have used a new technique for this discovery to show that a region...
India is Facing a Cancer Crisis
Apr 15, 2014  
India is currently facing a cancer crisis – reports a recent research carried out at the King’s college London, in collaboration with the Tata Memorial Cancer Centre, Mumbai.  The reasons estimated for this crisis comprise of increasing rates of smoking, unequal access to proper treatment and belated diagnosis.  Every year, India witnesses around one...
Microparticle Tags to Check Counterfeit Goods Invented
Apr 14, 2014  
Researchers from the Massachusetts Institute of Technology have invented a new set of microparticles that can easily be read by smartphones and establish the authenticity of currency, electronic items and luxury goods.  This strategy is among those countless measures taken by big brands and companies to label their legitimate products in order to stop illegal copies of the...
USFDA Approves Lupins Generic Diabetic Drug
Apr 10, 2014  
The United States Food and Drugs Administration (USFDA) has finally approved Lupin Pharmaceuticals Inc (LPI), the American subsidiary of Indian drug manufacturers Lupin Ltd, to sell Pioglitazone Tablets in the U.S market. The approval has been granted first for fiscal 2015.  Pioglitazone is a generic medicine used for managing diabetes and is a version of Actos tablets...
Infrared Sensors can Soon Be Used to Develop Night-Vision Lenses - A New Discovery Confirms
Apr 8, 2014  
People who fear the dark may soon have a reason to rejoice – an infrared sensor that can eventually be used for mechanizing night-vision lenses has been developed. This effectively means that one can also see through dark with the help of these lenses.  This technology seems possible all due to graphene, a layer of tightly packed carbon atoms that has allowed the creation of...